Establishment of a simple cell-based ELISA for the direct detection of abnormal isoform of prion protein from prion-infected cells without cell lysis and proteinase K treatment.

Mice devoid of PrP are resistant to scrapie. Cell (1993) 11.46

Eight prion strains have PrP(Sc) molecules with different conformations. Nat Med (1998) 9.01

Generating a prion with bacterially expressed recombinant prion protein. Science (2010) 6.26

Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet (2001) 5.57

Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science (2005) 5.52

The most infectious prion protein particles. Nature (2005) 5.37

Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science (2003) 4.57

The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive. J Biol Chem (1991) 4.23

The prion's elusive reason for being. Annu Rev Neurosci (2008) 3.23

Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells. J Virol (1993) 3.07

Protease-sensitive scrapie prion protein in aggregates of heterogeneous sizes. Biochemistry (2002) 2.36

A hypothalamic neuronal cell line persistently infected with scrapie prions exhibits apoptosis. J Virol (1997) 2.32

Synthesis and trafficking of prion proteins in cultured cells. Mol Biol Cell (1992) 2.14

Diagnosis of human prion disease. Proc Natl Acad Sci U S A (2005) 2.13

New inhibitors of scrapie-associated prion protein formation in a library of 2000 drugs and natural products. J Virol (2003) 2.09

Rapid cell-surface prion protein conversion revealed using a novel cell system. Nat Commun (2011) 2.04

Analysis of 27 mammalian and 9 avian PrPs reveals high conservation of flexible regions of the prion protein. J Mol Biol (1999) 1.90

Isolation and characterization of a proteinase K-sensitive PrPSc fraction. Biochemistry (2006) 1.86

Detection and characterization of proteinase K-sensitive disease-related prion protein with thermolysin. Biochem J (2008) 1.77

Single treatment with RNAi against prion protein rescues early neuronal dysfunction and prolongs survival in mice with prion disease. Proc Natl Acad Sci U S A (2008) 1.71

Identification of an intracellular site of prion conversion. PLoS Pathog (2009) 1.61

Discovery of 2-aminothiazoles as potent antiprion compounds. J Virol (2009) 1.51

Hot spots in prion protein for pathogenic conversion. Proc Natl Acad Sci U S A (2007) 1.31

Immunolocalisation of PrPSc in scrapie-infected N2a mouse neuroblastoma cells by light and electron microscopy. Eur J Cell Biol (2008) 1.14

Tricyclic antidepressants, quinacrine and a novel, synthetic chimera thereof clear prions by destabilizing detergent-resistant membrane compartments. J Neurochem (2006) 1.13

Cryo-immunogold electron microscopy for prions: toward identification of a conversion site. J Neurosci (2008) 1.12

Characterization of intracellular localization of PrP(Sc) in prion-infected cells using a mAb that recognizes the region consisting of aa 119-127 of mouse PrP. J Gen Virol (2011) 1.03

Antigenic characterization of an abnormal isoform of prion protein using a new diverse panel of monoclonal antibodies. Virology (2004) 1.01

Library synthesis and screening: 2,4-diphenylthiazoles and 2,4-diphenyloxazoles as potential novel prion disease therapeutics. J Med Chem (2007) 1.00

Cell-surface retention of PrPC by anti-PrP antibody prevents protease-resistant PrP formation. J Gen Virol (2004) 0.97

Variety of antiprion compounds discovered through an in silico screen based on cellular-form prion protein structure: Correlation between antiprion activity and binding affinity. Antimicrob Agents Chemother (2008) 0.95

Unique drug screening approach for prion diseases identifies tacrolimus and astemizole as antiprion agents. Proc Natl Acad Sci U S A (2013) 0.95

Anti-prion activity of a panel of aromatic chemical compounds: in vitro and in silico approaches. PLoS One (2014) 0.88

Characterization of prion susceptibility in Neuro2a mouse neuroblastoma cell subclones. Microbiol Immunol (2007) 0.84

Absence of CD14 delays progression of prion diseases accompanied by increased microglial activation. J Virol (2013) 0.83

Novel compounds lowering the cellular isoform of the human prion protein in cultured human cells. Bioorg Med Chem (2014) 0.81

Molecular characterization of chicken prion proteins by C-terminal-specific monoclonal antibodies. Vet Immunol Immunopathol (2008) 0.80

Characterization of intracellular dynamics of inoculated PrP-res and newly generated PrP(Sc) during early stage prion infection in Neuro2a cells. Virology (2014) 0.80

Diphenylpyrazole-derived compounds increase survival time of mice after prion infection. Antimicrob Agents Chemother (2011) 0.79

Cell density-dependent increase in the level of protease-resistant prion protein in prion-infected Neuro2a mouse neuroblastoma cells. J Gen Virol (2009) 0.79

Epitope mapping of a monoclonal antibody specific to feline panleukopenia virus and mink enteritis virus. J Vet Med Sci (1997) 0.78

Comparison of the anti-prion mechanism of four different anti-prion compounds, anti-PrP monoclonal antibody 44B1, pentosan polysulfate, chlorpromazine, and U18666A, in prion-infected mouse neuroblastoma cells. PLoS One (2014) 0.78